Trial Outcomes & Findings for Effect of Intra-operative Glove-changing During Cesarean Section on Post-op Complications: A Randomized Controlled Trial (NCT NCT02907892)

NCT ID: NCT02907892

Last Updated: 2018-08-17

Results Overview

Occurence of at least one of the following: wound seroma, wound hematoma, wound infection, skin separation of at least 1cm, or other incisional separation or abnormality requiring a bedside procedure to fix

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

554 participants

Primary outcome timeframe

Within 8 weeks following cesarean section

Results posted on

2018-08-17

Participant Flow

Participant milestones

Participant milestones
Measure
Control
Standard cesarean section surgical technique per surgeon preference
Glove Change
Cesarean section including changing of sterile surgical gloves immediately prior to abdominal closure Glove change: Intra-operative changing of sterile surgical gloves immediately prior to abdominal closure during cesarean section
Overall Study
STARTED
277
276
Overall Study
COMPLETED
250
236
Overall Study
NOT COMPLETED
27
40

Reasons for withdrawal

Reasons for withdrawal
Measure
Control
Standard cesarean section surgical technique per surgeon preference
Glove Change
Cesarean section including changing of sterile surgical gloves immediately prior to abdominal closure Glove change: Intra-operative changing of sterile surgical gloves immediately prior to abdominal closure during cesarean section
Overall Study
Lost to Follow-up
27
40

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control
n=277 Participants
Standard cesarean section surgical technique per surgeon preference
Glove Change
n=276 Participants
Cesarean section including changing of sterile surgical gloves immediately prior to abdominal closure Glove change: Intra-operative changing of sterile surgical gloves immediately prior to abdominal closure during cesarean section
Total
n=553 Participants
Total of all reporting groups
Age, Continuous
30.7 Years
STANDARD_DEVIATION 5.3 • n=277 Participants
30.6 Years
STANDARD_DEVIATION 5.4 • n=276 Participants
30.6 Years
STANDARD_DEVIATION 5.3 • n=553 Participants
Sex: Female, Male
Female
277 Participants
n=277 Participants
276 Participants
n=276 Participants
553 Participants
n=553 Participants
Sex: Female, Male
Male
0 Participants
n=277 Participants
0 Participants
n=276 Participants
0 Participants
n=553 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
277 participants
n=277 Participants
276 participants
n=276 Participants
553 participants
n=553 Participants

PRIMARY outcome

Timeframe: Within 8 weeks following cesarean section

Population: Participants with follow-up data (at least one postpartum visit within 8 weeks of delivery)

Occurence of at least one of the following: wound seroma, wound hematoma, wound infection, skin separation of at least 1cm, or other incisional separation or abnormality requiring a bedside procedure to fix

Outcome measures

Outcome measures
Measure
Control
n=250 Participants
Standard cesarean section surgical technique per surgeon preference
Glove Change
n=236 Participants
Cesarean section including changing of sterile surgical gloves immediately prior to abdominal closure Glove change: Intra-operative changing of sterile surgical gloves immediately prior to abdominal closure during cesarean section
Composite Wound Complication
34 Participants
15 Participants

Adverse Events

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Glove Change

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Rachel Vogel

University of Minnesota

Phone: 6513345982

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place